Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial
用户EO9nReo4Hj6s
1个月前
99
10
已完结
1. 系统已在2026-09-15 17:00:55对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1200/jco-25-02311
文献链接: https://ascopubs.org/doi/10.1200/JCO-25-02311
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: Sibylle Loibl; Michael Untch; Jens Huober; Vanessa Schaser; Michael Braun; Carsten Denkert; Andreas Hartkopf; Jens-Uwe Blohmer; Claus Hanusch; Theresa Link; Mattea Reinisch; Dirk-Michael Zahm; Rudolf Weide; Vesna Bjelic-Radisic; Peter Staib; Hans Tesch; Kerstin Rhiem; Ralf Lorenz; Julia Rey; Andreas Schneeweiss
